Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Pharmacology and Therapeutics

• Publication date

  2013-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.pharmthera.2013.03.003PMID 23531543PMCID PMC3686650
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prolonged survival time of allografts by the oral administration of RDP58 linked to the cholera toxin B subunit.

  2012cited by this paper
• Icaritin inhibits T cell activation and prolongs skin allograft survival in mice.

  2012cited by this paper
• TLR13 Recognizes Bacterial 23S rRNA Devoid of Erythromycin Resistance–Forming Modification

  2012cited by this paper
• Regulation of NF‐κB by ubiquitination and degradation of the IκBs

  2012cited by this paper
• Role of Toll-like receptors in primary Sjögren's syndrome with a special emphasis on B-cell maturation within exocrine tissues.

  2012cited by this paper
• Sequence specific detection of bacterial 23S ribosomal RNA by TLR13

  2012cited by this paper
• Recombinant chaperonin 10 suppresses cutaneous lupus and lupus nephritis in MRL-(Fas)lpr mice.

  2012cited by this paper
• TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome

  2012influential reference
• Regulation of cell death and autophagy by IKK and NF‐κB: critical mechanisms in immune function and cancer

  2012cited by this paper
• Treatment With OPN-305, a Humanized Anti–Toll-Like Receptor-2 Antibody, Reduces Myocardial Ischemia/Reperfusion Injury in Pigs

  2012cited by this paper
• Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy

  2011cited by this paper
• Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcγ receptor.

  2011influential reference
• Genetics of Systemic Sclerosis: An Update

  2011cited by this paper
• Expression of Toll-like Receptors and Their Signaling Pathways in Rheumatoid Synovitis

  2011cited by this paper
• The genetics of systemic sclerosis: an update.

  2011cited by this paper
• Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells

  2011cited by this paper
• TLR-dependent T cell activation in autoimmunity

  2011cited by this paper
• Genetic Risk Factors of Systemic Lupus Erythematosus in the Malaysian Population: A Minireview

  2011cited by this paper
• Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players

  2010cited by this paper
• Pathogenesis of Sjögren's syndrome and therapeutic consequences

  2010cited by this paper
• Immune Complexes Containing Citrullinated Fibrinogen Costimulate Macrophages via Toll-like Receptor 4 and Fc Receptor

  2010influential reference
• Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis

  2010cited by this paper
• Poly(I:C) drives type I IFN- and TGFβ-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis.

  2010cited by this paper
• Periodontitis in RA—the citrullinated enolase connection

  2010cited by this paper
• Expression of Toll-like receptors 7, 8, and 9 in primary Sjögren's syndrome.

  2010cited by this paper
• Structure-based analysis of Toxoplasma gondii profilin: a parasite-specific motif is required for recognition by Toll-like receptor 11.

  2010cited by this paper
• Hydroxychloroquine in SLE: old drug, new perspectives

  2010cited by this paper
• Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients.

  2010cited by this paper
• Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*

  2010cited by this paper
• Salivary epithelial cells from Sjogren's syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation.

  2010cited by this paper
• Systemic sclerosis and lupus: points in an interferon-mediated continuum.

  2010cited by this paper
• Effects of tobacco smoke on immunity, inflammation and autoimmunity.

  2010cited by this paper
• Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats

  2010cited by this paper
• A Novel, Highly Selective, Tight Binding IκB Kinase-2 (IKK-2) Inhibitor: A Tool to Correlate IKK-2 Activity to the Fate and Functions of the Components of the Nuclear Factor-κB Pathway in Arthritis-Relevant Cells and Animal Models

  2009cited by this paper
• Clinical Features and Treatment of Systemic Lupus Erythematosus

  2009cited by this paper
• Peripheral blood gene expression profiling in Sjögren’s syndrome

  2009cited by this paper
• Systemic Sclerosis and the Scleroderma-Spectrum Disorders

  2009cited by this paper
• Requirement for DNA CpG Content in TLR9-Dependent Dendritic Cell Activation Induced by DNA-Containing Immune Complexes1

  2009influential reference
• Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells.

  2009cited by this paper
• Clinical Features of Rheumatoid Arthritis

  2009cited by this paper
• Clinical Significance of Serum HMGB-1 and sRAGE Levels in Systemic Sclerosis: Association with Disease Severity

  2009cited by this paper
• Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention.

  2009cited by this paper
• The role of Toll-like receptors in rheumatoid arthritis

  2009cited by this paper
• Activating systemic autoimmunity: B's, T's, and tolls.

  2009cited by this paper
• Enhanced interleukin‐10 production by dendritic cells upon stimulation with Toll‐like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion

  2009cited by this paper
• Innate immunity and inflammation in systemic sclerosis

  2009cited by this paper
• Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4

  2009cited by this paper
• Critical Role of TLR2 and TLR4 in Autoantibody Production and Glomerulonephritis in lpr Mutation-Induced Mouse Lupus1

  2009cited by this paper
• A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.

  2009cited by this paper
• RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model.

  2008cited by this paper
• Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA)

  2008cited by this paper
• Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis.

  2008cited by this paper
• Inhibitors of TLR8 Reduce TNF Production from Human Rheumatoid Synovial Membrane Cultures1

  2008cited by this paper
• The role of toll-like receptors in macrophages.

  2008cited by this paper
• Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function.

  2008influential reference
• TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.

  2008cited by this paper
• B cell autonomous TLR signaling and autoimmunity.

  2008cited by this paper
• Single-Stranded Oligonucleotides Can Inhibit Cytokine Production Induced by Human Toll-Like Receptor 3

  2008cited by this paper
• TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus.

  2008cited by this paper
• Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis.

  2008cited by this paper
• The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions.

  2008cited by this paper
• Toll-Like Receptor Expression and Responsiveness of Distinct Murine Splenic and Mucosal B-Cell Subsets

  2007cited by this paper
• Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population

  2007cited by this paper
• Toll-like receptors and innate immunity in B-cell activation and antibody responses.

  2007cited by this paper
• Rheumatoid arthritis is linked to Proteus—the evidence

  2007cited by this paper
• Toll-like receptor in salivary glands from patients with Sjögren's syndrome: functional analysis by human salivary gland cell line.

  2007cited by this paper
• Ligand-induced conformational changes allosterically activate Toll-like receptor 9

  2007cited by this paper
• Non-enterobacterial endotoxins stimulate human coronary artery but not venous endothelial cell activation via Toll-like receptor 2.

  2007cited by this paper
• Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis.

  2007cited by this paper
• Toll-like receptor 4 signal transduction inhibitor, M62812, suppresses endothelial cell and leukocyte activation and prevents lethal septic shock in mice.

  2007cited by this paper
• Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis.

  2007cited by this paper
• Repression of Inflammatory Gene Expression in Human Pulmonary Epithelial Cells by Small-Molecule IκB Kinase Inhibitors

  2007cited by this paper
• The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

  2007cited by this paper
• Expression of functional Toll‐like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome

  2007cited by this paper
• Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation.

  2007cited by this paper
• Cutting Edge: Diminished T Cell TLR Expression and Function Modulates the Immune Response in Human Filarial Infection1

  2006cited by this paper
• Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.

  2006cited by this paper
• IKKβ inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis

  2006cited by this paper
• Mode of action of hydroxychloroquine in RA—evidence of an inhibitory effect on toll-like receptor signaling

  2006cited by this paper
• IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis.

  2006cited by this paper
• Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.

  2006cited by this paper
• Conserved Features in the Extracellular Domain of Human Toll-like Receptor 8 Are Essential for pH-dependent Signaling*

  2006cited by this paper
• A Tlr7 translocation accelerates systemic autoimmunity in murine lupus.

  2006cited by this paper
• HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2

  2006influential reference
• Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE.

  2006influential reference
• U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7.

  2006cited by this paper
• Human Effector CD8+ T Lymphocytes Express TLR3 as a Functional Coreceptor1

  2006cited by this paper
• Toll-like receptor 9 signaling protects against murine lupus.

  2006cited by this paper
• Toll-like receptors in systemic autoimmune disease

  2006cited by this paper
• Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome.

  2006cited by this paper
• The type I interferon system in systemic lupus erythematosus.

  2006cited by this paper
• Role of TLR9 in Anti-Nucleosome and Anti-DNA Antibody Production in lpr Mutation-Induced Murine Lupus1

  2006cited by this paper
• TLR4 Up-Regulation at Protein or Gene Level Is Pathogenic for Lupus-Like Autoimmune Disease1

  2006cited by this paper
• Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial.

  2006cited by this paper
• RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3.

  2005influential reference
• A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus.

  2005cited by this paper
• Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

  2005influential reference
• Recognition of Double-stranded RNA by Human Toll-like Receptor 3 and Downstream Receptor Signaling Requires Multimerization and an Acidic pH*

  2005cited by this paper
• The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.

  2005cited by this paper
• Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells

  2005cited by this paper

• Renal macrophage TLR7 signaling in lupus nephritis: from pathogenic mechanisms to therapeutic opportunities

  2026cites this paper
• Decoding the Pathophysiology of Autoimmune Diseases—Mechanism, Triggers, and Nanotherapeutics: A Review

  2026cites this paper
• Emerging trends and focus of Toll-like receptors in kidney diseases: a 20-year bibliometric analysis

  2025cites this paper
• RNA polymerase II subunit 5-mediating protein limits TLR4-induced innate immune activation in macrophages by inhibiting IKKβ/NF-κB signaling during sepsis

  2025cites this paper
• The role of double-negative B cells in the pathogenesis of systemic lupus erythematosus.

  2025cites this paper
• The potential of prebiotics, probiotics, and synbiotics for ameliorating intestinal barrier dysfunction and modulating inflammatory responses as dietary supplements in diabetes mellitus management

  2025cites this paper
• Modulating Metabolic Health and Physiological Functions: Advances in Dietary Interventions Targeting Gut Microbiota

  2025cites this paper
• Risk of autoimmune disease flares after recombinant zoster vaccine: A vaccine safety analysis based on the Vaccine Adverse Event Reporting System database

  2025cites this paper
• The therapeutic effects of dendrobium officinale polysaccharides on diabetes mellitus: from the perspective of gut microbiota

  2025cites this paper
• Influence of Maqian essential oil on gut microbiota and immunoresponses in type 1 diabetes: In silico study

  2024cites this paper
• Toll-like receptor signaling pathway involved in pathogenesis of thromboangiitis obliterans through activating of NF-κB

  2024cites this paper
• Interplay of Chemokines Receptors, Toll-like Receptors, and Host Immunological Pathways

  2023cites this paper
• Modulation of type I interferon signaling by natural products in the treatment of immune-related diseases.

  2023cites this paper
• RNAi-mediated CrebA silencing inhibits reproduction and immunity in Locusta migratoria manilensis.

  2023cites this paper
• Mitochondrial DNA-Sensing Pathogen Recognition Receptors in Systemic Sclerosis-Associated Interstitial Lung Disease: a Review

  2023cites this paper
• From Gut to Glucose: A Comprehensive Review on Functional Foods and Dietary Interventions for Diabetes Management.

  2023cites this paper
• Alleviation of experimental autoimmune encephalomyelitis by transferring low RelB expression tolerogenic dendritic cells.

  2023cites this paper
• Myelodysplastic syndrome and autoimmune disorders: two sides of the same coin?

  2022cites this paper
• The Role of the Gut Microbiota in the Pathogenesis of Diabetes

  2022cites this paper
• Microbiota in health and diseases

  2022influential citation
• Role of gut microbiota in the pathogenesis and treatment of diabetes mullites: Advanced research-based review

  2022cites this paper
• Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine

  2021cites this paper
• Activation of Toll-Like Receptor 7 Signaling Pathway in Primary Sjögren's Syndrome-Associated Thrombocytopenia

  2021cites this paper
• Study on the antidepressant effect of panaxynol through the IκB-α/NF-κB signaling pathway to inhibit the excessive activation of BV-2 microglia.

  2021cites this paper
• Role of the Innate Immunity Signaling Pathway in the Pathogenesis of Sjögren’s Syndrome

  2021cites this paper
• Therapeutic Potential of IL-9 in Allergic and Autoimmune Diseases

  2021cites this paper
• MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer

  2021cites this paper
• Loss of toll-like receptor 4 ameliorates cardiovascular dysfunction in aged mice

  2021cites this paper
• Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems

  2021cites this paper
• Toll-Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility

  2021cites this paper
• Structure-activity relationship study of dihydroartemisinin C-10 hemiacetal derivatives as Toll-like receptor 4 antagonists.

  2021cites this paper
• Aiming at ideal therapeutics- MOPr/DOPr or MOPr-DOPr heteromer-targeting ligand.

  2020cites this paper
• Variety of endosomal TLRs and Interferons (IFN‐α, IFN‐β, IFN‐γ) expression profiles in patients with SLE, SSc and MCTD

  2020cites this paper
• Downregulation of Inflammatory Cytokine Release from IL-1β and LPS-Stimulated PBMC Orchestrated by ST2825, a MyD88 Dimerisation Inhibitor

  2020cites this paper
• Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms

  2020influential citation
• Long noncoding RNA (MEG3) in urinal exosomes functions as a biomarker for the diagnosis of Hunner‐type interstitial cystitis (HIC)

  2020cites this paper
• Inflammatory Role of TLR-MyD88 Signaling in Multiple Sclerosis

  2020cites this paper
• Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases

  2020cites this paper
• Rationally designed small-molecule inhibitors targeting an unconventional pocket on the TLR8 protein-protein interface.

  2020cites this paper
• Multiple Processes May Involve in the IgG4-RD Pathogenesis: An Integrative Study via Proteomic and Transcriptomic Analysis

  2020cites this paper
• A flavonoid monomer tricin in Gramineous plants: Metabolism, bio/chemosynthesis, biological properties, and toxicology.

  2020cites this paper
• Interferons (IFN-A/-B/-G) Genetic Variants in Patients with Mixed Connective Tissue Disease (MCTD)

  2019cites this paper
• Multiple sclerosis, the microbiome, TLR2, and the hygiene hypothesis.

  2019cites this paper
• Innate Immune Cells' Contribution to Systemic Lupus Erythematosus

  2019cites this paper
• [The Involvement of Src in Airway Inflammation Induced by Repeated Exposure to Lipopolysaccharide in Mice].

  2019cites this paper
• Effects of MiR-146a on repair and inflammation in rats with spinal cord injury through the TLR/NF-κB signaling pathway.

  2019cites this paper
• Paeoniflorin inhibits activation of the IRAK1-NF-κB signaling pathway in peritoneal macrophages from lupus-prone MRL/lpr mice.

  2018cites this paper
• Gut Microbiota and Type 1 Diabetes

  2018influential citation
• Role of Microglia TLRs in Neurodegeneration

  2018cites this paper
• Bergenin loaded gum xanthan stabilized silver nanoparticles suppress synovial inflammation through modulation of the immune response and oxidative stress in adjuvant induced arthritic rats.

  2018cites this paper
• Current and Emerging Evidence for Toll-Like Receptor Activation in Sjögren's Syndrome

  2018cites this paper
• Small Molecule Analogues of the parasitic worm product ES-62 interact with the TIR domain of MyD88 to inhibit pro-inflammatory signalling

  2018cites this paper
• Small Molecule Analogues of the parasitic worm product ES ┽ びは interact with the TIR domain of MyDふふ to inhibit pro ┽ in ━ ammatory signalling

  2018cites this paper
• The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis

  2018cites this paper
• Targeting TLRs and the inflammasome in systemic sclerosis

  2018cites this paper
• Clinical and immunological parameters of Sjögren's syndrome.

  2018cites this paper
• Betulinic acid and fluvastatin exhibits synergistic effect on toll-like receptor-4 mediated anti-atherogenic mechanism in type II collagen induced arthritis.

  2017cites this paper
• Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics

  2017cites this paper
• Toll-like receptor 7 is overexpressed in the bladder of Hunner-type interstitial cystitis, and its activation in the mouse bladder can induce cystitis and bladder pain

  2017cites this paper
• Protein Tyrosine Phosphatases in Systemic Sclerosis: Potential Pathogenic Players and Therapeutic Targets

  2017cites this paper
• Innate immunity in Sjögren's syndrome.

  2017cites this paper
• Toll-Like Receptor-4 Signaling Drives Persistent Fibroblast Activation and Prevents Fibrosis Resolution in Scleroderma

  2017cites this paper
• TLR‐Induced SMPD3 Defects Enhance Inflammatory Response of B Cell and Macrophage in the Pathogenesis of SLE

  2017cites this paper
• Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation

  2017cites this paper
• Intramembrane attenuation of the TLR4-TLR6 dimer impairs receptor assembly and reduces microglia-mediated neurodegeneration

  2017cites this paper
• The epigenetic architecture at gene promoters determines cell type-specific LPS tolerance.

  2017cites this paper
• Homeostatic Inflammation as Environmental-Adaptation Strategy

  2016cites this paper
• Tissue-specific mRNA expression profiles of porcine Toll-like receptors at different ages in germ-free and conventional pigs.

  2016cites this paper
• Whole-genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus

  2016cites this paper
• The complement receptor 3 (CD11b/CD18) agonist Leukadherin‐1 suppresses human innate inflammatory signalling

  2016cites this paper
• The expression profile of toll-like receptor signaling molecules in CD19(+) B cells from patients with primary immune thrombocytopenia.

  2016cites this paper
• Therapeutic Developments Targeting Toll‐like Receptor‐4‐Mediated Neuroinflammation

  2016cites this paper
• Association of HLA‐DRB1 alleles with susceptibility to mixed connective tissue disease in Polish patients

  2016cites this paper
• Association of HLA-DRB1 alleles with susceptibility to mixed connective tissue disease in Polish patients.

  2016cites this paper
• Activating transcriptional factor 3 in joint inflammatory pain: exploring mechanisms at the sensory ganglia

  2016cites this paper
• Update on the role of plasmacytoid dendritic cells in inflammatory/autoimmune skin diseases

  2016cites this paper
• Drugs in early clinical development for Systemic Lupus Erythematosus

  2016influential citation
• Induced by TLR 7 Inhibitor for Psoriasis-like Inflammation Identification of Thiostrepton as a Novel

  2015cites this paper
• Identification of Thiostrepton as a Novel Inhibitor for Psoriasis-like Inflammation Induced by TLR7–9

  2015cites this paper
• Effect of Antiretroviral Therapy on Damage-Associated Molecular Patterns (DAMPs). Lipopolysacharide (LPS) and Immune Reconstitution in HIV-Infected Individuals

  2015cites this paper
• Endosomes and Toll-Like Receptors-Role in Autoimmunity

  2015influential citation
• Mechanism of anti-inflammatory effect of tricin, a flavonoid isolated from Njavara rice bran in LPS induced hPBMCs and carrageenan induced rats.

  2015cites this paper
• What can we learn from systemic lupus erythematosus pathophysiology to improve current therapy?

  2015cites this paper
• A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus

  2015cites this paper
• The Role of Damage-Associated Molecular Patterns in Human Diseases: Part I - Promoting inflammation and immunity.

  2015cites this paper
• Association of Toll like receptor Asp299Gly with rheumatoid arthritis risk: a systematic review of case-control studies and meta-analysis.

  2015cites this paper
• Increased activation of toll-like receptors-7 and -8 of peripheral blood mononuclear cells and upregulated serum cytokines in patients with pediatric systemic lupus erythematosus.

  2015cites this paper
• Increased expression of TLR2 in CD4+ T cells from SLE patients enhances immune reactivity and promotes IL‐17 expression through histone modifications

  2015cites this paper
• Dioscin attenuates renal ischemia/reperfusion injury by inhibiting the TLR4/MyD88 signaling pathway via up-regulation of HSP70.

  2015cites this paper
• Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes

  2015cites this paper
• The treatment of rheumatoid arthritis using Chinese medicinal plants: From pharmacology to potential molecular mechanisms.

  2015cites this paper
• The Parasitic Worm Product ES-62 Targets Myeloid Differentiation Factor 88–Dependent Effector Mechanisms to Suppress Antinuclear Antibody Production and Proteinuria in MRL/lpr Mice

  2015cites this paper
• U1-RNP and Toll-like receptors in the pathogenesis of mixed connective tissue diseasePart II. Endosomal TLRs and their biological significance in the pathogenesis of mixed connective tissue disease

  2015cites this paper
• U1-RNP and TLR receptors in the pathogenesis of mixed connective tissue diseasePart I. The U1-RNP complex and its biological significance in the pathogenesis of mixed connective tissue disease

  2015cites this paper
• Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus

  2015cites this paper
• The Parasitic Worm Product ES-62

  2015cites this paper
• Emerging Roles of Innate Immune Signaling and Toll-Like Receptors in Fibrosis and Systemic Sclerosis

  2015cites this paper
• Green tea polyphenols change the profile of inflammatory cytokine release from lymphocytes of obese and lean rats and protect against oxidative damage.

  2015cites this paper
• ACTIVATION OF TOLL LIKE RECEPTOR 7 INDUCES CYSTITIS AND FACILITATION OF BLADDER PAIN AND MECHANO-SENSATION IN MICE

  2015cites this paper
• TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review

  2014cites this paper